Functional Medicine is Longevity Medicine(TM) Masterclass to Redefine the Future of Healthspan
Free 3-day online event brings together 30+ global leaders to unite functional and longevity medicine with cutting-edge science and clinical...
Brain
123Invent Inventor Develops Brain-Computer Interface & Defense System (MHO-628)
PITTSBURGH, Sept. 4, 2025 /PRNewswire/ -- "I wanted to create a wireless, non-invasive brain-computer interface to facilitate direct communication between...
PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics
Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (the "Company" or...
BrainSpec and University of Minnesota Collaborate to Advance Automation in MR Spectroscopy with AutoVOI
The enhancement of virtual biopsy technology automates traditional manual methods of selecting regions of the brain for Magnetic Resonance Spectroscopy...
Hoth Therapeutics Taps Lantern Pharma’s PredictBBB.ai Platform — Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it...
Hemostemix’s VesCell.Health Launched in Florida
Calgary, Alberta--(Newsfile Corp. - September 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
Novel human preclinical neuronal model for Parkinson’s disease demonstrated CNM-Au8’s ability to improve mitochondrial health, restore cellular metabolism, reduce inflammation,...
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG) today announced compelling preclinical results for...
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
PRINCETON, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage,...
SeoulTech Scientist Develops Artificial Synapses That Mimic Human Brain Function for Next-Gen AI Chips
The innovative organic materials proposed by Dr. Eunho Lee and his team bring us closer to brain-like computer processors In...
SeoulTech Develop Hybrid Polymer-CNT Electrodes for Safer Brain-Machine Interfaces
Flexible carbon nanotube-based electrodes achieve high conductivity in brain connections with minimum tissue damage SEOUL, South Korea, Sept. 3, 2025...
Brainomix Stroke AI Software Hailed as ῾Revolutionary,’ Helping More Patients Fully Recover
OXFORD, England and CHICAGO, Sept. 3, 2025 /PRNewswire/ -- Brainomix, a global leader and pioneer of AI-powered imaging tools in...
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...
Howie’s 17+ Years After VesCell(TM): Following Hemostemix’s Heart Patients
Calgary, Alberta--(Newsfile Corp. - September 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA...
Dr. Robert Melillo and ‘A Moment of Xen’ join forces to bring ‘Brain-Based Wellness’ to National Radio, Digital Streaming TV, and social platforms
NEW YORK, Sept. 2, 2025 /PRNewswire/ -- 'A Moment of Xen', the acclaimed Tri-State talk show hosted by celebrated media...
Neurophet Signs MoU with InRAD to Establish Global Standards for Alzheimer’s disease and Dementia Data
Neurophet's AI-based brain imaging analysis solutions to support global standardization of Alzheimer's and other dementia-related dataEnhancing dementia research by integrating...
Countdown to the Longevity Investors Conference 2025: Where Science, Innovation, and Investment Meet in Gstaad
Zug, Switzerland--(Newsfile Corp. - September 2, 2025) - Longevity Investors, launched back in 2020 as the first industry event series...
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European...
Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software
Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European...